Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.100
+0.020 (1.85%)
At close: Mar 6, 2026
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.23 billion as of March 6, 2026. Its market cap has decreased by -25.53% in one year.
Market Cap
2.23B
Enterprise Value
3.06B
Revenue
1.99B
Ranking
n/a
PE Ratio
74.02
Stock Price
1.10
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.23B, a decrease of -66.84%. That is a compound annual growth rate of -15.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.23B | 10.00% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.14B |
| BioDlink International Company | 3.13B |
| SinoMab BioScience | 2.70B |
| Jiangsu Recbio Technology | 2.65B |
| Clover Biopharmaceuticals | 2.31B |
| Antengene Corporation | 2.15B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.96B |
| Zhaoke Ophthalmology | 1.74B |